Galenvs Sciences Inc.
$527,000.00 CAD
≈ 7 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- July 10, 2023 – March 15, 2025
- Reference
- nrc-cnrc:172-2023-2024-Q2-1008172
Published purpose
The Firm seeks to advance the state of the art in aptamer drug development through the development of novel chemistries of non-natural or modified natural nucleotides and synthesis and purification methods for a large DNA-encoded aptamer library. The technology will leverage core expertise in the design and manufacturing of magnetic nanoparticles and in-house large-scale high-purity synthesis of oligonucleotide services to provide the biopharmaceutical and biotechnology industry with products and services that will accelerate the design and screening of aptamers for therapeutic drug discovery.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions